A. Paull, A. Kerr Grant
Abstract
A double blind controlled trial was performed to assess the symptomatic benefit of oral metoclopramide in patients with gastro-oesophageal reflux. In the 31 patients studied, metoclopramide was not clearly superior to the placebo but definite conclusions could not be drawn because of the small numbers.
OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A double blind controlled trial was performed to assess the symptomatic benefit of oral metoclopramide in patients with gastro-oesophageal reflux. In the 31 patients studied, metoclopramide was not clearly superior to the placebo but definite conclusions could not be drawn because of the small numbers.
Key concepts: Metoclopramide, Reflux, Placebo, Medicine, Gastroenterology, Internal medicine, Rabeprazole, Double blind